Wellfully Ltd. logo

Wellfully Ltd. (WFL)

Delisted
ASX ASX
1.48M Market Cap
- P/E Ratio
- Div Yield
725,177 Volume
- Eps
Want to track WFL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.

Wellfully Ltd. (WFL) FAQ

What does "Delisted" mean?

Wellfully Ltd. has been removed from the exchange and is no longer publicly traded.

What was the last recorded dividend?

The last recorded dividend was paid on Mar 03, 2010 in the amount of A$0.02 per share.

How long did the company pay dividends?

The company paid dividends for 8 years prior to delisting.

Were there any stock splits?

No stock splits were recorded prior to delisting.

What was the last known trading price?

The stock last traded at A$0.00 on Jul 24, 2024 before being delisted.

Wellfully Ltd. Profile

- Industry
- Sector
Mr. Paul Peros CEO
ASX Exchange
AU0000105033 ISIN
Australia Country
- Employees
3 Mar 2010 Last Dividend
19 Feb 2020 Last Split
- IPO Date

Overview

Wellfully Limited, originally known as OBJ Limited until its rebranding in September 2020, is an innovative company that is at the forefront of the research and development sphere, focusing on advanced drug delivery technologies. This operation is specifically designed around the principles of Dermaportation and Electrophoresis Transdermal Patch (ETP) technologies. This specialization allows the company to excel in creating sophisticated delivery methods for pharmaceuticals through the skin, making treatments more efficient and user-friendly. Established in 1992 and headquartered in Leederville, Australia, Wellfully Limited not only pioneers in its technical domain but also ensures the industrialization and effective supply-chain integration for its diverse range of products. The company serves a broad spectrum of sectors including pharmaceuticals, cosmetics and skincare, and consumer healthcare, highlighting its versatile approach towards improving health and wellness outcomes through innovative technology.

Products and Services

Wellfully Limited’s portfolio is segmented into two main categories: Dermaportation Drug Delivery Technology and Devices. Each segment represents a facet of the company's commitment to bringing innovative solutions to market.

  • Dermaportation Drug Delivery Technology: This cornerstone technology developed by Wellfully allows for the non-invasive delivery of drugs through the skin using unique methods that enhance the absorption and effectiveness of various compounds. It is a pivotal breakthrough for the pharmaceutical industry, especially in the treatment of conditions where traditional oral or injectable drug delivery presents challenges.
  • Devices: Wellfully Limited is also engaged in the development and marketing of devices that are used alongside or as a part of their Dermaportation technology. These devices are designed to facilitate the delivery of drugs or cosmetic products more efficiently into the skin.
  • REDUIT: As one of Wellfully’s proprietary brands, REDUIT focuses on the innovation of personal care devices and products. The brand emphasizes enhancing the effectiveness and absorption of skincare and haircare products, thereby reducing waste and improving consumer experience.
  • SWISSWELL: Under this brand, Wellfully extends its expertise into the realm of skincare technology, offering a range of products that leverage the company’s advanced delivery systems to improve skin health and appearance.
  • Third-Party Collaborations: Acknowledging the power of synergy, Wellfully Limited actively seeks and undertakes collaborations with other companies. These partnerships aim to combine Wellfully’s proprietary technologies with external expertise or distribution networks, thereby expanding their reach and impact within various healthcare, cosmetic, and consumer sectors.

Contact Information

Address: 284 Oxford Street
Phone: 61 8 9443 3011